Abstract
We have comparatively evaluated Quantiplex version 3.0 and version 2. 0 on 133 plasma samples and a repetitive dilution series. Version 3. 0 yielded higher human immunodeficiency virus RNA values, and the ratio of version 3.0 results to version 2.0 results decreased from 3. 47 below 1,000 copies/ml to 1.97 above 50,000 copies/ml [linear regression, log (version 3.0) = 0.915 + 0.871 x log (version 2.0); r(2) = 0.952].
MeSH Terms
DNA Probes
Evaluation Studies as Topic
HIV Infections/virology
HIV-1/genetics,physiology
Humans
Nucleic Acid Hybridization
RNA, Viral/blood,genetics
Reagent Kits, Diagnostic
Viral Load
Chemicals
DNA Probes
RNA, Viral
Reagent Kits, Diagnostic
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Manegold C
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Heinrich-Heine-Universität, Düsseldorf, Germany. manegold@bni.uni-hamburg.de
Krempe C
Jablonowski H
Kajala L
Dietrich M
Adams O
References (17)
17 references, click to expand
-
Statistical methods for assessing agreement between two methods of clinical measurement.
Lancet. 1986 Feb 8;1(8476):307-10
PMID: 2868172
-
Variance of plasma human immunodeficiency virus type 1 RNA levels measured by branched DNA within and between days.
J Infect Dis. 1997 Aug;176(2):514-7
PMID: 9237721
-
Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.
J Clin Microbiol. 1998 Mar;36(3):716-20
PMID: 9508301
-
Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma.
J Clin Microbiol. 1998 Mar;36(3):835-9
PMID: 9508327
-
The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir.
AIDS. 1998 Mar 26;12(5):F9-14
PMID: 9543434
-
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy.
AIDS. 1998 Sep 10;12(13):1619-24
PMID: 9764780
-
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
Science. 1996 May 24;272(5265):1167-70
PMID: 8638160
-
Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Oct 1;13(2):127-39
PMID: 8862277
-
An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma.
J Clin Microbiol. 1996 Dec;34(12):3196-202
PMID: 8940471
-
Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
J Med Virol. 1996 Dec;50(4):293-302
PMID: 8950685
-
Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection.
Science. 1997 May 9;276(5314):960-4
PMID: 9139661
-
Decay characteristics of HIV-1-infected compartments during combination therapy.
Nature. 1997 May 8;387(6629):188-91
PMID: 9144290
-
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response. ACTG 241 Protocol Virology Substudy Team.
Ann Intern Med. 1997 Jun 15;126(12):929-38
PMID: 9182469
-
Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS.
Ann Intern Med. 1997 Jun 15;126(12):939-45
PMID: 9182470
-
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.
Ann Intern Med. 1997 Jun 15;126(12):946-54
PMID: 9182471
-
A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.
Nucleic Acids Res. 1997 Aug 1;25(15):2979-84
PMID: 9224596
-
Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.
Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12574-9
PMID: 9356491